Ruscica, M.; Macchi, C.; Gandini, S.; Macis, D.; Guerrieri-Gonzaga, A.; Aristarco, V.; Serrano, D.; Lazzeroni, M.; Rizzuto, A.S.; Gaeta, A.;
et al. Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study. Cancers 2024, 16, 1411.
https://doi.org/10.3390/cancers16071411
AMA Style
Ruscica M, Macchi C, Gandini S, Macis D, Guerrieri-Gonzaga A, Aristarco V, Serrano D, Lazzeroni M, Rizzuto AS, Gaeta A,
et al. Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study. Cancers. 2024; 16(7):1411.
https://doi.org/10.3390/cancers16071411
Chicago/Turabian Style
Ruscica, Massimiliano, Chiara Macchi, Sara Gandini, Debora Macis, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Davide Serrano, Matteo Lazzeroni, Alessandra Stefania Rizzuto, Aurora Gaeta,
and et al. 2024. "Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study" Cancers 16, no. 7: 1411.
https://doi.org/10.3390/cancers16071411
APA Style
Ruscica, M., Macchi, C., Gandini, S., Macis, D., Guerrieri-Gonzaga, A., Aristarco, V., Serrano, D., Lazzeroni, M., Rizzuto, A. S., Gaeta, A., Corsini, A., Gulisano, M., Johansson, H., & Bonanni, B.
(2024). Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study. Cancers, 16(7), 1411.
https://doi.org/10.3390/cancers16071411
